期刊
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
卷 172, 期 8, 页码 4062-4077出版社
HUMANA PRESS INC
DOI: 10.1007/s12010-014-0804-7
关键词
Advanced glycation end products; Dendritic cell; Heart failure; Myocardial infarct
资金
- National Natural Science Foundation of China [81072641, 81273499]
- National Science and Technology Major Project of China [2011ZX09401-307]
- Team item of Natural Science Foundation of Guangdong Province [S2011030003190]
Advanced glycation end products (AGEs) and dendritic cells (DCs) are believed to play a key role in the development and progression of cardiovascular diseases. However, their role and interactive mechanism remain uncertain. The aim of the present study is to investigate the mechanism of AGE- and DC-mediated heart failure. Time- and dose-dependent western blot and immunohistochemical analysis showed a significant upregulation in the expression of AGEs, receptor for AGEs (RAGE), and OX-62. Further hemodynamic and echocardiogram analysis revealed that AGEs mediate cardiac failure. Treatment with pioglitazone improved heart function by decreasing the expression of AGEs and OX-62 in the rats with myocardial infarction (MI) plus diabetes. AGEs induced the maturation of DCs in both time- and concentration-dependent manner with upregulation in RAGE and dendritic markers. Further, coculture of cardiomyocytes with DCs in the presence of AGEs significantly upregulated hypertrophy-associated genes as determined by real-time PCR. In conclusion, the present study shows clear evidence that AGEs promote heart failure via the maturation of DCs. In addition, inhibition of AGEs by pioglitazone alleviates accumulation of DCs and thus improves heart function.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据